On January 8th, 2020, the 9th Viet Nam Congress of Congenital and Structural Heart Disease was grandly held in Ho Chi Minh City, Vietnam. The implantation surgery of IBS Angel™ iron bioabsorbable scaffold, independently developed by Biotyx, has achieved great success. The present experts in the cardiovascular field gave a high evaluation of IBS Angel™.
On January 8th, 2020, the 9th Viet Nam Congress of Congenital and Structural Heart Disease was grandly held in Ho Chi Minh City, Vietnam. This conference invited many authoritative experts of domestic and foreign and industry companies to participate. It focused on exchanging and discussing the interventional treatment of congenital and structural heart disease and valvular disease from a multi-angle through various forms.
On the morning of January 8th, the most attractive surgery live broadcast of this meeting was conducted at the prime time of the highly anticipated main venue. It was led by Mazeni Alwi, a famous expert in the field of global pediatric congenital heart from the National Heart Institute of Malaysia. The professor used the IBS® Angel™ iron bioabsorbable scaffold, developed by Biotyx, for PDA scaffold implantation. This is Professor Mazeni Alwi once again showed to the global audience that he used the IBS® Angel™ iron bioabsorbable scaffold for PDA scaffold implantation after the CSI Frankfurt 2019 conference. The IBS® Angel™ iron bioabsorbable scaffold provides a survival time for the next scheduled cardiac surgery. The entire operation took a short time, with very smooth process, and achieved great success.
The IBS® Angel™ iron bioabsorbable scaffold, developed by Biotyx, is one of the IBS®™ iron bioabsorbable vascular scaffold products, which can be used for temporary support of children's arterial catheters, pulmonary arteries and right ventricular outflow tract. The IBS® Angel™ iron bioabsorbable scaffold has many advantages and is very suitable for children with complicated arterial catheter-dependent congenital heart disease and children with congenital pulmonary vascular disease. Its small size makes it suitable for neonates and infants; its absorbable characteristics make it unnecessary to remove the scaffold during subsequent heart surgery, which reduce damage to the pulmonary artery, facilitate the ligation of the arterial catheter, and reduce heart surgery complication. Professor Mazeni Alwi successfully demonstrated the excellent product design and excellent handling performance of the IBS® Angel™ iron bioabsorbable scaffold. The present experts in the cardiovascular field all highly praised IBS® Angel™.
(Professor Mazeni Alwi uses IBS® Angel™ iron bioabsorbable scaffold for live broadcast of surgery)
